PF-03382792

CAS No. 1400811-63-3

PF-03382792( PF-3382792 )

Catalog No. M11670 CAS No. 1400811-63-3

PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 540 Get Quote
10MG 770 Get Quote
25MG 1152 Get Quote
50MG 1575 Get Quote
100MG 2124 Get Quote
500MG 4257 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PF-03382792
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.
  • Description
    PF-03382792 (PF-3382792) is a clinical compound under phase 1 investigation for an unknown indication.Other Indication Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PF-3382792
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    1400811-63-3
  • Formula Weight
    433.52
  • Molecular Formula
    C23H32FN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N1C(C(C)(C)C2=C1C=C(F)C=C2)=O)NCC3CCN(CC4(O)CCOCC4)CC3
  • Chemical Name
    1H-Indole-1-carboxamide, 6-fluoro-2,3-dihydro-3,3-dimethyl-2-oxo-N-((1-((tetrahydro-4-hydroxy-2H-pyran-4-yl)methyl)-4-piperidinyl)methyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • H-Arg-4MβNA

    H-Arg-4MβNA (H-Arg-4MbNA) is a peptide that serves as a substrate for cathepsin H. The enzyme activity is often detected in gel electrophoresis.

  • Phyllanthusiin C

    Phyllanthusiin C is a natural product of Terminalia, Combretaceae. Phyllanthusiin C can be used as a reference standard.

  • GKI-1

    GKI-1 is a Greatwall (GWL) kinase inhibitor with an IC50 of 4.9 for hGWLFL and 2.5 μM for hGWL-KinDom. It exhibits stronger inhibition on ROCK1 with an IC50 of 11 μM and only weakly inhibits PKA.